Related Experiment Videos
[Nitric oxide donors and retinal vein occlusion]
G Donati1, A D Kapetanios, C J Pournaras
1Clinique d'Ophtalmologie, Dpt. des Neurosciences cliniques, Genève.
Klinische Monatsblatter Fur Augenheilkunde
|July 27, 1999
Summary
Administering nitric oxide (NO) donors reversed arteriolar vasoconstriction following branch vein occlusion (BVO) in pigs. This suggests NO therapy may protect the retina from ischemic injury after BVO.
Area of Science:
- Ophthalmology
- Vascular Biology
- Retinal Research
Context:
- Branch vein occlusion (BVO) leads to nonperfused capillaries and arteriolar constriction.
- Local nitric oxide (NO) release is impaired post-BVO, contributing to vasoconstriction.
- Understanding the role of NO in BVO is crucial for developing therapeutic strategies.
Purpose:
- To investigate the role of local nitric oxide (NO) in secondary arteriolar vasoconstriction after branch vein occlusion (BVO).
- To determine if NO donor administration can reverse arteriolar vasoconstriction following BVO.
Summary:
- Experimental BVO in miniature pigs induced arteriolar vasoconstriction and decreased preretinal nitric oxide (NO) levels within 4 hours.
- Microinjection of the NO donor Sodium Nitroprusside (SNP) resulted in reversible arteriolar dilation.
- These findings demonstrate that NO administration can counteract BVO-induced arteriolar constriction.
Impact:
- Local NO supply in the early hours after BVO may offer retinal protection against ischemic damage.
- This research highlights the potential of NO-based therapies for managing complications of retinal vascular occlusive diseases.
- The study provides evidence for a therapeutic window for NO intervention following BVO.